甲状腺癌与桥本甲状腺炎并存。
Coexistent carcinoma of the thyroid gland and Hashimoto's thyroiditis.
作者信息
Strauss M, Laurian N, Antebi E
出版信息
Surg Gynecol Obstet. 1983 Sep;157(3):228-32.
Three instances of Hashimoto's thyroiditis occurring in association with carcinoma of the thyroid gland are presented. Diagnosis was made by open surgical biopsy, revealing one papillary, one follicular and one mixed papillary-follicular carcinoma. Total thyroidectomy was performed and TSH suppressive therapy was administered postoperatively. All patients are alive with no evidence of local recurrence or distant metastases observed during five to 13 years of follow-up study. In our series, three of 18 patients had coexistent carcinoma of the thyroid gland and Hashimoto's disease. This figure is lower than the 25 per cent incidence of carcinoma of the thyroid gland in noninflammatory goiters observed at the same hospital. Although the number of patients is small, Hashimoto's thyroiditis does not seem to be a premalignant lesion and should not be treated by total thyroidectomy. A review of the literature points out that clinical, biochemical and radioactive scan findings in patients with Hashimoto's thyroiditis do not aid in differentiating between glands with or without coexistent carcinoma of the thyroid gland unless the goiter is uninodular and cold on the radioiodine scan. The prognosis of patients with carcinoma of the thyroid gland occurring in association with Hashimoto's disease is probably better than that of patients with carcinoma of the thyroid gland alone. It seems that the presence of the chronic inflammatory reaction may suppress growth and metastatic dissemination of the coexistent neoplasm of the thyroid gland.
本文报告了3例桥本甲状腺炎合并甲状腺癌的病例。通过开放性手术活检确诊,分别为1例乳头状癌、1例滤泡状癌和1例乳头状 - 滤泡状混合癌。均行甲状腺全切除术,术后给予促甲状腺激素(TSH)抑制治疗。在5至13年的随访研究中,所有患者均存活,无局部复发或远处转移迹象。在我们的病例系列中,18例患者中有3例同时存在甲状腺癌和桥本氏病。这一数字低于同一家医院在非炎性甲状腺肿中观察到的甲状腺癌25%的发病率。尽管患者数量较少,但桥本甲状腺炎似乎不是癌前病变,不应行甲状腺全切除术。文献综述指出,除非甲状腺肿在放射性碘扫描中为单结节且呈冷结节,否则桥本甲状腺炎患者的临床、生化及放射性扫描结果无助于鉴别甲状腺是否合并癌。桥本氏病合并甲状腺癌患者的预后可能优于单纯甲状腺癌患者。似乎慢性炎症反应的存在可能会抑制共存的甲状腺肿瘤的生长和转移扩散。